A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients

NCT01780844 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

149

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplantation

Interventions

DRUG: ASKP1240
DRUG: Tacrolimus
DRUG: Mycophenolate Mofetil (MMF)
DRUG: Basiliximab
DRUG: Methylprednisone
DRUG: Prednisone

Sponsor

Astellas Pharma Global Development, Inc.

Collaborators

[object Object]